Channel Therapeutics Corporation

Go to Channel Therapeutics Corporation Website

$13.50

(%)
Live
Previous Close

$13.5

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$

Day Vol.

Previous Day Vol.

Currency

Primary Exchange

None

...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Channel Therapeutics, a biotechnology company focused on developing non-opioid pain treatments, announced that its 2024 audited financial statements contained a going concern emphasis of matter paragraph, as required by NYSE American listing rules.

Related tickers: CHRO.

Read Full Article

Ligand Pharmaceuticals and Channel Therapeutics announced a merger agreement, where Ligand's Pelthos Therapeutics subsidiary will be combined with Channel. The combined company will focus on commercializing Pelthos' FDA-approved ZELSUVMI for the treatment of Molluscum contagiosum infections.

Related tickers: LGND, CHRO.

Read Full Article
Trending Tickers

Please sign in to view